| Literature DB >> 22529839 |
Abstract
The bioavailability ofEntities:
Keywords: bioavailability; biogeochemistry; iron; organic complexation; phytoplankton; redox reactions; speciation; uptake
Year: 2012 PMID: 22529839 PMCID: PMC3328120 DOI: 10.3389/fmicb.2012.00123
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 2Summary of processes, systems, and research fields which are influenced by iron inputs and bioavailability (see text for details).
Figure 1A conceptual diagram disassembling the multivariable concept of iron bioavailability to phytoplankton. The figure outlines the composing facets of Fe bioavailability where green text highlights topics elaborated in the paper. At the most basic level, the availability of an iron species to a phytoplankton species is determined by the rate at which it is acquired by the organism. Fe uptake rate, in turn, is a function of the uptake pathways expressed by an organism and the chemical compatibility or exchange kinetics of the Fe-substrate with the transport systems (upper box). In Sections “Fundamentals of Fe Bioavailability: Phytoplankton Fe Acquisition Systems” and “Fundamentals of Fe Bioavailability: Phytoplankton Fe Acquisition Rates” we discuss the experimental evaluation of Fe uptake rates by laboratory cultures and natural populations. In the environment, many other chemical, biological, and physical factors are important for determining Fe availability to phytoplankton, some of which are detailed in the lower box. In Section “Added Complexity to Bioavailability: Bio-Mediated Transformations of Fe Speciation” we turn to organism–Fe interactions and discuss how secretion of organic compounds and bio-mediated redox processes alter Fe speciation and influence Fe availability.
Figure 3Prevalence of the reductive iron uptake pathway amongst phytoplankton. Listed are laboratory cultures and natural environments for which inhibition of uptake by Fe(II) binding ligands (Ferrozine/BPDS) was observed experimentally and taken to indicate the formation of an Fe(II) intermediate during iron transport. For some species, genomic and proteomic research identified various components of the reductive iron uptake pathway including ferrireductases and multicopper oxidases. See Appendix for supporting data and methodology (Tables A1 and A2 and Figures A1 and A2 in Appendix). Note on locations: The Gulf of Aqaba is located at the northern tip of the Red Sea, Loch Scridain is a sea loch located on the Atlantic coastline of the island of Mull, Scotland, and Lake Kinneret (Sea of Galilee) is a fresh water lake in the north of Israel. References: aEckhardt and Buckhout (1998), bWeger (1999), cKeshtacher et al. (1999), dAllnutt and Bonner (1987), eMiddlemiss et al. (2001), fSasaki et al. (1998), gShaked et al. (2002), hShaked et al. (2005), iJones and Morel (1988), jMaldonado and Price (2001), kSoria-Dengg and Horstmann (1995), lKranzler et al. (2011), mFujii et al. (2010), nRose et al. (2005), oMaldonado et al. (2005), pMaldonado and Price (1999), qShaked et al. (2004), rLis and Shaked (2009), ‡Lis and Shaked, in preparation.
Experimental evidence showing the existence of an iron reductive uptake pathway in laboratory cultures.
| Organism | Type of evidence | Reference |
|---|---|---|
| FZ/BPDS inhibits uptake, Fe reduction | Kustka et al. ( | |
| Genetic – Fe reductase, multi-Cu oxidase | ||
| FZ/BPDS inhibits uptake; Fe reduction | Jones et al. ( | |
| FZ/BPDS inhibits uptake; Fe reduction | Maldonado and Price ( | |
| Cu induced Fe uptake inhibition multi-Cu oxidase | ||
| FZ/BPDS inhibits uptake; Fe reduction | Lis and Shaked (in preparation) | |
| FZ/BPDS inhibits uptake; Fe reduction | Soria-Dengg and Horstmann ( | |
| FZ/BPDS inhibits uptake; Fe reduction | Shaked et al. ( | |
| FZ/BPDS inhibits uptake | Lis and Shaked (in preparation) | |
| Fe reduction; Genetic – Fe reductase, multi-Cu oxidase | Eckhardt and Buckhout ( | |
| Fe reduction; Genetic – Fe reductase | Keshtacher et al. ( | |
| FZ/BPDS inhibits uptake; Fe reduction EPR | Allnutt and Bonner ( | |
| Fe reduction | Middlemiss et al. ( | |
| Fe reduction | Sasaki et al. ( | |
| FZ/BPDS inhibits uptake; Fe reduction | Lis and Shaked (in preparation) | |
| FZ/BPDS inhibits uptake; Fe reduction | Lis and Shaked (in preparation) | |
| FZ/BPDS inhibits uptake; Fe reduction | Lis and Shaked (in preparation) | |
| FZ/BPDS inhibits uptake; Fe reduction | Kranzler et al. ( | |
| FZ/BPDS inhibits uptake; Fe reduction | Fujii et al. ( | |
| FZ/BPDS inhibits uptake; Fe reduction | Rose et al. ( | |
| FZ/BPDS inhibits uptake; Fe reduction | Shaked (unpublished) |
Experimental evidence showing the existence of the reductive iron uptake pathway in field populations.
| Field location | Type of evidence | Reference |
|---|---|---|
| Southern ocean | Calculation | Maldonado et al. ( |
| Subarctic Pacific (>3 μm) | Uptake | Maldonado and Price ( |
| Bering Sea (>5 μm) | Uptake | Shaked et al. ( |
| Gulf of Aqaba (>0.2 μm) | Uptake | Lis and Shaked ( |
| Loch Scridain (>20 μm) | Uptake | Lis and Shaked (in preparation) |
| Lake Kinneret | Uptake | Shaked et al. ( |
Figure A1Trapping of ferrous iron formed during Fe′ reduction with ferrozine (Fz) or Bathophenanthrolinedisulfonic acid (BPDS). The Fe(II) trap competes with cells over ferrous iron formed during cell-mediated Fe reduction. The structures of two such traps – ferrozine and BPDS – are shown on the right top and bottom respectively. Fe(II)Fz3 and Fe(II)BPDS3 are detected spectrophotometrically at 562 and 533 nm, respectively. Additionally Fe(II)Fz3 and inhibition of Fe uptake by Fz/BPDS can be detected in radioactive experiments. Figure based on Lis and Shaked (2009).
Figure A2Experimental data of iron uptake by . The uptake of iron from 90 nM 55FeDFB by iron limited Synechococcus WH8102 was inhibited in the presence of 200 μM Fz. The inhibitory effect stems from the trapping of Fe(II) formed through cell surface enzymatic reduction during Fe uptake.
Figure 5Relative scale of Fe availability established from phytoplankton uptake rates obtained for cultures (A) and natural assemblages (B). By converting experimental data to uptake-rate constants, and normalizing it further relative to Fe’, comparisons across organisms, Fe-substrates and environments are made possible (see text and Figure 4 for details). Different Fe-complexes are presented as different colors, while bar length represents variations among experiments, and circles denote no uptake. Abbreviations: Goe, goethite; DFB, desferrioxamine B; AB, Aerobactin; FC, ferrichrome; PYN, Porphyrin; MS, Monosaccharides; PS, Polysaccharides; AZ, Azotochelin; DPS, DNA binding protein from starved cells (iron storage proteins); CAT, Gallocatechin; DFE, desferrioxamine E. See Appendix for supporting data and Figure 3 for location descriptions. References: aShaked et al. (2005), bChen et al. (2008:1], cNodwell and Price (2001), dKustka et al. (2005), eMaldonado and Price (2001), fHassler and Schoemann (2009), gHassler et al. (2011b), hKranzler et al. (2011), iMaldonado and Price (1999), jMaldonado et al. (2005), kWells et al. (1994); lLis and Shaked (2009), ‡Lis and Shaked, unpublished.
Figure 4Schematic representation of experimental probing and calculation of the uptake rate constant – . Note that the complexing ligand L for strong ligands such as DFB should be in sufficient excess of Fe to rule out the presence of Fe′ (which would bias uptake rate since Fe′ is taken up more readily than FeL). But L:Fe should be minimal to prevent ligand from competing with cells for Fe (and thus decreasing uptake rates).
A comparison between the minimal daily Fe requirements and the daily FeDFB uptake capacity of .
| Daily FeDFB uptake capacity: | Minimal daily Fe requirement: Q × μ | ||
|---|---|---|---|
| [Fe]− | μ− | ||
| Uptake rate constant for FeDFB | Fe-substrate concentration | intracellular Fe quota for | Fe-limited growth rate |
| ∼3 × 10-13 L cell−1 day−1 | ∼4 × 10−9 mol L−1 | ∼10−18 mol cell−1 | ∼0.4 day−1 |
| ∼1.2 × 10−21 mol Fe cell−1 day−1 | ∼4 × 10−18 mol Fe cell−1 day−1 | ||
Minimal daily Fe requirements are calculated by multiplying intracellular Fe quota (Q) by Fe-limited growth rates (μ). Uptake capacity is calculated by multiplying .
.
.
.
.
Figure 6Selected examples of biological interactions with external iron inputs (e.g., aeolian dust deposition, sediment resuspension, fluvial, and hydrothermal Fe) and organism mediated influences on iron speciation and recycling in aquatic environments. While the microbial web in its entirety (from grazers to primary producers, viruses and heterotrophic bacteria) influences iron dynamics and availability to all community members, we focus on resultant Fe bioavailability to photosynthetic microorganisms. Abbreviations: dFe, dissolved iron; cFe, colloidal iron; pFe, particulate Fe. References: aSander and Koschinsky (2011), bWu et al. (2011), cLohan and Bruland (2008), dSevermann et al. (2010), eBatchelli et al. (2010), fBoyd et al. (2010b), gRubin et al. (2011), hBarbeau et al. (1996), iTang et al. (2011), jSato et al. (2007), kBuck et al. (2010), lBalzano et al. (2009), mMaldonado and Price (1999), nShaked et al. (2002), oHiggins et al. (2009), pStrzepek et al. (2005), qTsuda et al. (2007), rBoyd et al. (2010a), sBoyd and Ellwood (2010), tKuma et al. (1996).
Figure 7Redox reactions of different Fe species in aquatic environments. See Table 2 below for details on processes 1–6 in the figure.
Redox reactions of different Fe species in aquatic environments, their governing factors, and potential influence on Fe speciation and bioavailability (this table accompanies Figure .
| Mediators and governing factors | Effects on speciation and bioavailability | References |
|---|---|---|
| • O2, | • Fe(III) formation and subsequent hydrolysis and precipitation, decreases bioavailability | a–c |
| •’Regulated by pH, temp, salinity | ||
| •’Enzymatic– phytoplankton (assimilatory) & bacteria (dissimilatory – low oxygen) | •’Elevated [Fe(II)s.s] and maintenance of active redox cycle, both of which slow down Fe(III) hydrolysis and precipitation | d–g |
| •’Direct photolysis or reduction by photo-produced reactive transients | • Availability is enhanced when [Fe′] increases (as Fe(III) and Fe(II) are equally bioavailable) | |
| •’ | ||
| •’Humic and fulvic acids | ||
| •’Enzymatic (as above) | • Weaker ligand binding to Fe(II) (compared to Fe(III)L) may favor dissociation of free Fe(II) and increase in [Fe′] and bioavailability | h–i |
| •’O2, | • Rates are slower/faster than Fe(II) oxidation resulting in elevated/lowered [Fe(II)Ls.s] | j–k |
| •’Bacterial dissimilatory reduction in aggregates | •’Elevated [Fe′] due to increased Fe(II) flux | l–m |
| •’Ingested colloids (zooplankton) | •’Elevated FeL (when ligands are at play) | |
| • Direct photolysis and light enhanced siderophore mediated dissolution | • Dissolution enhances bioavailability as solid phase iron is largely inaccessible | |
| •’O2 and mineral surfaces (O2 oxidizes surface bound Fe(II) much faster than dissolved Fe(II)) | •’ If oxidation precedes detachment of Fe(II): decreased flux of Fe(II) | n |
[Fe(II)s.s] , steady state Fe(II) concentrations.
References: a. Santana-Casiano et al. (.
The influence of siderophore and saccharide release on iron chemistry and availability in aquatic environments.
| Siderophores | Saccharides (EPS, TEP) |
|---|---|
| Strongly bound organic dFe & cFe Fe(III)L | Organically bound/adsorbed dFe, cFe, & pFe |
| dFe, cFe, & pFe | dFe & cFe |
| • Maintain Fe in solution | • Maintain Fe in solution or promote its aggregation and export from photic zone |
| Photochemical reduction | • Photochemical reduction |
| Heterotrophic bacteria, fresh water phytoplankton | Phytoplankton, Bacteria, Viruses, Zooplankton |
| Varies between complexes and organisms but probably lower compared to Fe′ | As high as Fe′ for all studied organisms |
| a–f | g–m |
dFe, dissolved iron; cFe, colloidal iron; pFe, particulate Fe.
References: a. Sandy and Butler (.
Data used in the calculation of relative bioavailability of laboratory cultures (Figure .
| Organism | Fe Ligand | Avg | Units | Rel. bioavail | Reference | Notes |
|---|---|---|---|---|---|---|
| Fe′ | 4.6E−09 | L−1 cell−1 h−1 | Shaked et al. ( | Fe(diss) estimated at 0.1 nM | ||
| Fe′ | 2.9E−07 | L−1 μm−2 h−1 | Chen et al. ( | Based on growth rates | ||
| Fe′ | 3.7E+07 | L−1 mol−1 day−1 | Nodwell and Price ( | |||
| DFB | 6.0E−13 | L−1 cell−1 h−1 | 1.3E−04 | Shaked et al. ( | Fe:DFB (1:5) | |
| DFB | 7.2E−10 | L−1 μm−2 h−1 | 2.5E−03 | Chen and Wang ( | Fe:DFB (1:1.1) | |
| Ferrichrome | 1.2E−10 | L−1 μm−2 h−1 | 4.1E−04 | Chen and Wang ( | Fe:FC (1:200) | |
| Goethite | 0 | 0 | Nodwell and Price ( | Based on growth rates | ||
| DFB | 0 | 0 | Chen and Wang ( | Fe:DFB (1:5) | ||
| Ferrichrome | 0 | 0 | Chen and Wang ( | Fe:FC (1:200) | ||
| Fe′ | 12.9E−10 | L−1 cell−1 h−1 | Kranzler et al. ( | |||
| DFB | 6.6E−14 | L−1 cell−1 h−1 | 3.4E−04 | Kranzler et al. ( | Fe:DFB (1:1.3) | |
| Aerobactin | 2.3E−13 | L−1 cell−1 h−1 | 1.2E−03 | Kranzler et al. ( | Fe:AB (1:2.3) | |
| Fe′ | 4.1E−09 | L−1 cell−1 h−1 | Hassler and Schoemann ( | ∼30% of FeCl3 in dissolved phase | ||
| DFB | 6.10E−11 | L−1 cell−1 h−1 | 1.5E−02 | Hassler and Schoemann ( | Fe:DFB (1:15) | |
| Monosaccharides | 4.8E−09 | L−1 cell−1 h−1 | 1.2 | Hassler and Schoemann ( | Fe:MS (1:15) | |
| Polysaccharides | 6.2E−09 | L−1 cell−1 h−1 | 1.53 | Hassler and Schoemann ( | Fe:PS (1:15) | |
| Fe′ | 4.2E−08 | L−1 μm−2 h−1 | Chen and Wang ( | Fe(diss) estimated at 0.1 nM | ||
| Fe′ | 2.2E−11 | L−1 cell−1 h−1 | Lis and Shaked (in preparation) | |||
| DFB | 2.8E−11 | L−1 μm−2 h−1 | 6.7E−04 | Chen and Wang ( | Fe:DFB (1:5) | |
| DFB | 1.2E−14 | L−1 cell−1 h−1 | 5.4E−04 | Lis and Shaked (in preparation) | Fe:DFB (1:2) | |
| Ferrichrome | 2.0E−11 | L−1 μm−2 h−1 | 4.8E−04 | Chen and Wang ( | Fe:FC (1:200) | |
| Fe′ | 6.00E−08 | L−1 cell−1 h−1 | Shaked et al. ( | Fe′ from Shaked et al. ( | ||
| DFB | 2.90E−11 | L−1 cell−1 h−1 | 4.8E−04 | Shaked et al. ( | Fe:DFB (1:1.1) | |
| DFB | 2.56E−11 | L−1 cell−1 h−1 | 4.3E−04 | Shi et al. ( | Fe:DFB (1:2) | |
| Ferrichrome | 1.6E−10 | L−1 cell−1 h−1 | 2.7E−03 | Shaked et al. ( | ||
| Deuteroporphyrin | 1.9E−10 | L−1 cell−1 h−1 | 3.2E−03 | Kustka et al. ( | ||
| Grazed Fe | 3.4E−11 | L−1 cell−1 h−1 | 5.6E−04 | Shi et al. ( | ||
| Fe-Azotochelin | 1.6E−10 | L−1 cell−1 h−1 | 2.7E−03 | Shi et al. ( | ||
| Fresh ferrihydrite | 3.3E−10 | L−1 cell−1 h−1 | 5.6E−03 | Shi et al. ( | ||
| Fe-dPS | 4.5E−11 | L−1 cell−1 h−1 | 7.5E−04 | Shi et al. ( | ||
| Fe′ | 2.56E−08 | L−1 cell−1 h−1 | Maldonado and Price ( | |||
| DFB | 4.0E−12 | L−1 cell−1 h−1 | 1.6E−04 | Maldonado and Price ( | Fe:DFB (1:10) | |
| Fe′ | 2.0E+07 | L−1 mol−1 day−1 | Nodwell and Price ( | Based on growth rates | ||
| DFB | 0 | L−1 mol−1 day−1 | 0 | Nodwell and Price ( | Based on growth rates | |
| Goethite | 5.0E+05 | L−1 mol−1 day−1 | 2.53E−02 | Nodwell and Price ( | Based on growth rates | |
| Fe′ | 2.0E−09 | L−1 cell−1 h−1 | Hassler and Schoemann ( | ∼30% of FeCl3 in dissolved phase | ||
| DFB | 6.1E−11 | L−1 cell−1 h−1 | 3.1E−02 | Hassler and Schoemann ( | Fe:DFB (1:15) | |
| Monosaccharides | 2.6E−09 | L−1 cell−1 h−1 | 1.3E+00 | Hassler and Schoemann ( | Fe:MS (1:15) | |
| Polysaccharides | 3.5E−09 | L−1 cell−1 h−1 | 1.8E+00 | Hassler and Schoemann ( | Fe:PS (1:15) | |
| Fe′ | 3.67E−08 | L−1 cell−1 h−1 | Hassler and Schoemann ( | ∼30% of FeCl3 in dissolved phase | ||
| DFB | 6.1E−11 | L−1 cell−1 h−1 | 1.7E−03 | Hassler and Schoemann ( | Fe:DFB (1:15) | |
| Monosaccharides | 2.9E−08 | L−1 cell−1 h−1 | 7.9E−01 | Hassler and Schoemann ( | Fe:MS (1:15) | |
| Polysaccharides | 3.5E−08 | L−1 cell−1 h−1 | 9.6E−01 | Hassler and Schoemann ( | Fe:PS (1:15) | |
Data used in the calculation of relative bioavailability of natural assemblages (Figure .
| Field study location | Fe ligand | Avg | Units | Rel. bioavail. | Reference | Notes |
|---|---|---|---|---|---|---|
| Coastal (station P4) | Fe′ | 9.2E−01 | L−1 mol−1 C h−1 | Data taken from 1996 study performed along line P which runs from coast (P4, high Fe) to offshore (P26, lower Fe) waters | ||
| DFB | 7.3E−03 | 8.0E−03 | Maldonado and Price ( | |||
| DFE | 7.7E−03 | 8.3E−03 | ||||
| Offshore (station P26) | Fe′ | 5.8E−02 | FeL at ratio of 1:5 for DFB and DFE | |||
| DFB | 3.2E−03 | 5.4E−02 | ||||
| DFE | 3.1E−03 | 5.2E−02 | ||||
| South of polar front | Fe′ | 2.5E−13 | L−1 h−1 | Hassler et al. ( | Fe′ assumed to be 1 nM | |
| DFB | 5.0E−14 | 2.0E−01 | Uptake rates from lowest concentration of ligand additions | |||
| Monsaccharides | 3.8E−13 | 1.5E+00 | ||||
| Fe′ | 2.6E+02 | L−1 mol−1 C h−1 | Uptake rates from dark experiments | |||
| FeDFB | 7.9E+00 | 3.0E−02 | ||||
| Gallocatechin | 4.8E+02 | 1.8E+00 | FeL is 1:10 for organic ligands, DFB, and Gallocatechin | |||
| 1.1E+02 | 4.2E−01 | |||||
| Upwelling region | FeDFB | 0 | 0 | Wells et al. ( | Fe:DFB (1:5); population dominated by | |
| Fe′ | 7.9E−02 | L−1 mol−1 | 7.0E−05 | Lis and Shaked (in preparation) | Fe:DFB (1:2); population dominated by | |
| DFB | 5.6E−06 | |||||
| Fe′ | 1.6E−01 | Lis and Shaked (in preparation) | Fe:DFB (1:2); population dominated by | |||
| FeDFB | 2.5E−04 | 1.6E−03 | ||||